Elanco Animal Health Incorporated ELAN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -66.67% | -5.26% | 120.65% | -711.76% | -409.09% |
| Total Depreciation and Amortization | 3.64% | -0.60% | -1.19% | 0.00% | 4.35% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | -25.00% | 0.00% |
| Total Other Non-Cash Items | 85.71% | -40.43% | 413.33% | -183.33% | 260.00% |
| Change in Net Operating Assets | -229.17% | 109.13% | -216.89% | 281.36% | 13.46% |
| Cash from Operations | -22.02% | 2,030.77% | -87.96% | -50.68% | -7.59% |
| Capital Expenditure | -81.82% | 35.29% | 17.74% | 32.61% | -61.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 88.89% | -350.00% | 77.78% | -1,000.00% |
| Cash from Investing | 43.64% | -83.33% | 6.25% | 36.63% | -80.36% |
| Total Debt Issued | -100.00% | -- | -- | 626.21% | -- |
| Total Debt Repaid | -74.80% | -668.75% | 99.24% | -1,020.74% | 57.85% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00% | 97.06% | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 11.76% | 93.33% | -187.63% |
| Cash from Financing | -191.89% | -13.85% | -261.11% | 88.24% | 1.92% |
| Foreign Exchange rate Adjustments | -133.33% | 280.00% | -135.71% | 1,300.00% | -96.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -163.73% | 187.18% | -392.50% | 217.65% | -165.38% |